IDEAYA Biosciences Announces Positive Phase 2 Data for Darovasertib in Uveal Melanoma

IDEAYA Biosciences announced that data from a Phase 2 clinical trial of neoadjuvant darovasertib in primary uveal melanoma will be presented at the 20...
Home/KnloSights/Clinical Trial Updates/IDEAYA Biosciences Announces Positive Phase 2 Data for Darovasertib in Uveal Melanoma